Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Shares Outstanding (Weighted Average) (2023 - 2025)

Rallybio (RLYB) has disclosed Shares Outstanding (Weighted Average) for 3 consecutive years, with $5.6 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 3.42% to $5.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.6 million through Dec 2025, up 3.42% year-over-year, with the annual reading at $5.6 million for FY2025, 3.42% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $5.6 million in Q4 2025 for Rallybio, down from $45.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $45.1 million in Q3 2025 to a low of $5.4 million in Q4 2024.
  • Historically, Shares Outstanding (Weighted Average) has averaged $36.3 million across 3 years, with a median of $40.6 million in 2023.
  • Biggest YoY gain for Shares Outstanding (Weighted Average) was 10.43% in 2024; the steepest drop was 86.54% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $40.4 million in 2023, then crashed by 86.54% to $5.4 million in 2024, then increased by 3.42% to $5.6 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for RLYB at $5.6 million in Q4 2025, $45.1 million in Q3 2025, and $44.8 million in Q2 2025.